Northpointe Capital Raised Neogenomics (NEO) Position; Kopp Investment Advisors Has Boosted Callidus Software (CALD) Stake

December 7, 2017 - By Vivian Currie

Northpointe Capital Llc increased Neogenomics Inc (NEO) stake by 91.81% reported in 2017Q2 SEC filing. Northpointe Capital Llc acquired 443,710 shares as Neogenomics Inc (NEO)’s stock declined 8.15%. The

Northpointe Capital Llc holds 927,008 shares with $8.31M value, up from 483,298 last quarter. Neogenomics Inc now has $740.57M valuation. The stock increased 0.77% or $0.07 during the last trading session, reaching $9.21. About 211,658 shares traded. NeoGenomics, Inc. (NASDAQ:NEO) has declined 13.46% since December 7, 2016 and is downtrending. It has underperformed by 30.16% the S&P500.

Kopp Investment Advisors Llc increased Callidus Software (CALD) stake by 25.32% reported in 2017Q2 SEC filing. Kopp Investment Advisors Llc acquired 28,580 shares as Callidus Software (CALD)’s stock rose 3.72%. The Kopp Investment Advisors Llc holds 141,436 shares with $3.42 million value, up from 112,856 last quarter. Callidus Software now has $1.84 billion valuation. The stock increased 2.27% or $0.6 during the last trading session, reaching $27.05. About 422,953 shares traded or 29.65% up from the average. Callidus Software Inc. (NASDAQ:CALD) has risen 22.29% since December 7, 2016 and is uptrending. It has outperformed by 5.59% the S&P500.

Investors sentiment increased to 1.08 in 2017 Q2. Its up 0.09, from 0.99 in 2017Q1. It increased, as 9 investors sold CALD shares while 52 reduced holdings. 18 funds opened positions while 48 raised stakes. 62.28 million shares or 0.06% less from 62.31 million shares in 2017Q1 were reported. New York-based Morgan Stanley has invested 0% in Callidus Software Inc. (NASDAQ:CALD). Jane Street Grp Limited Liability has invested 0% of its portfolio in Callidus Software Inc. (NASDAQ:CALD). Citigroup has 5,213 shares for 0% of their portfolio. 576,701 were reported by Citadel Advsrs Llc. Nationwide Fund Advsr has 192,516 shares for 0.02% of their portfolio. Voya Inv Limited Liability Company accumulated 29,376 shares. Meeder Asset Mngmt Inc owns 39 shares. Summit Creek Advisors Limited Co holds 505,676 shares or 2.52% of its portfolio. Kennedy Mgmt Incorporated stated it has 613,713 shares or 0.28% of all its holdings. Manufacturers Life Ins The stated it has 49,772 shares or 0% of all its holdings. Aqr Cap Limited Co accumulated 0% or 9,627 shares. Aperio Gru Lc holds 60,908 shares or 0.01% of its portfolio. First Mercantile Co owns 0.06% invested in Callidus Software Inc. (NASDAQ:CALD) for 13,440 shares. Jennison Associates Ltd Llc reported 976,924 shares. Hood River Cap Mgmt Ltd has invested 0.4% in Callidus Software Inc. (NASDAQ:CALD).

Among 11 analysts covering Callidus Software (NASDAQ:CALD), 9 have Buy rating, 1 Sell and 1 Hold. Therefore 82% are positive. Callidus Software had 27 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Callidus Software Inc. (NASDAQ:CALD) earned “Buy” rating by Dougherty & Company on Wednesday, December 2. The stock has “Buy” rating by Piper Jaffray on Sunday, December 3. On Wednesday, July 19 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Oppenheimer with “Buy” on Monday, September 18. Oppenheimer maintained it with “Buy” rating and $30.0 target in Friday, September 29 report. Oppenheimer maintained the shares of CALD in report on Friday, June 30 with “Buy” rating. The stock has “Buy” rating by Roth Capital on Thursday, June 22. The rating was maintained by Northland Capital on Friday, July 31 with “Outperform”. On Friday, April 1 the stock rating was reinitiated by Piper Jaffray with “Overweight”. The stock of Callidus Software Inc. (NASDAQ:CALD) has “Outperform” rating given on Friday, November 6 by Northland Capital.

Investors sentiment increased to 1.18 in 2017 Q2. Its up 0.13, from 1.05 in 2017Q1. It is positive, as 19 investors sold NEO shares while 32 reduced holdings. 17 funds opened positions while 43 raised stakes. 60.13 million shares or 3.48% more from 58.11 million shares in 2017Q1 were reported. Cambridge reported 13,100 shares. 255,489 were accumulated by Hightower Advsrs Limited Liability Co. Regions Financial accumulated 18,752 shares. Artisan Prtnrs Limited Partnership has 2.36 million shares for 0.04% of their portfolio. Geneva Advsr Limited Liability Com holds 123,771 shares. Campbell & Invest Adviser Ltd Liability holds 0.11% or 13,140 shares. Rmb Capital Lc invested in 977,964 shares or 0.25% of the stock. 6,400 were reported by Great West Life Assurance Com Can. Metropolitan Life Insur Ny holds 38,841 shares or 0% of its portfolio. Deutsche Natl Bank Ag owns 77,315 shares. Penn Capital reported 0.19% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO). Commonwealth Equity Services has invested 0% in NeoGenomics, Inc. (NASDAQ:NEO). Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 3,530 shares or 0% of the stock. Price T Rowe Assocs Md holds 0% or 14,746 shares in its portfolio. Financial Bank Of Montreal Can, a Ontario – Canada-based fund reported 59,953 shares.

Northpointe Capital Llc decreased Bank Of The Ozarks Inc (NASDAQ:OZRK) stake by 16,893 shares to 210,864 valued at $9.88M in 2017Q2. It also reduced Tivo Corp stake by 17,100 shares and now owns 382,727 shares. Biospecifics Technologies Co (NASDAQ:BSTC) was reduced too.

Among 11 analysts covering NeoGenomics (NASDAQ:NEO), 9 have Buy rating, 1 Sell and 1 Hold. Therefore 82% are positive. NeoGenomics had 17 analyst reports since September 3, 2015 according to SRatingsIntel. BTIG Research downgraded the stock to “Neutral” rating in Wednesday, July 27 report. Axiom Capital downgraded the shares of NEO in report on Wednesday, November 16 to “Sell” rating. Cantor Fitzgerald initiated NeoGenomics, Inc. (NASDAQ:NEO) on Thursday, December 15 with “Overweight” rating. On Sunday, September 6 the stock rating was maintained by William Blair with “Outperform”. Cantor Fitzgerald maintained NeoGenomics, Inc. (NASDAQ:NEO) rating on Friday, May 26. Cantor Fitzgerald has “Buy” rating and $1100 target. The rating was downgraded by BTIG Research on Monday, September 11 to “Neutral”. The stock of NeoGenomics, Inc. (NASDAQ:NEO) has “Buy” rating given on Friday, May 26 by Roth Capital. As per Tuesday, October 4, the company rating was initiated by First Analysis. The company was maintained on Thursday, September 3 by Roth Capital. TH Capital reinitiated it with “Buy” rating and $10.0 target in Monday, October 26 report.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>